Status:
RECRUITING
A Registered Cohort Study on SMA
Lead Sponsor:
Wan-Jin Chen
Conditions:
Spinal Muscular Atrophy
Eligibility:
All Genders
1-70 years
Brief Summary
Spinal muscular atrophy (SMA) is an autosomal recessive disease that causes progressive muscle wasting and weakness due to loss of motor neurons in the spinal cord. This is a registered cohort of spin...
Eligibility Criteria
Inclusion
- Patients with SMA types I, II and III
- Asymptomatic SMA carriers
- Relatives of SMA patients or carriers
- Unrelated healthy controls
- Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process
Exclusion
- \* Participants are unable to comply with trial procedures and visit schedule
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2049
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04010604
Start Date
July 1 2019
End Date
December 31 2049
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China, 350005